Dr. David M. Oberlin, MD

Dr. Oberlin practices at Forefront Dermatology, S.C. in Grand Rapids, Michigan.

Dr. Oberlin's NPI, 1376924902, was assigned on June 9, 2015. Dr. Oberlin graduated from Wayne State University School of Medicine in 2015. Dr. Oberlin holds Michigan license 4301117195.

Dr. Oberlin's primary practice is Forefront Dermatology, S.C., at 2525 E Paris SE Ave, Grand Rapids, MI 49546 in Kent County. The practice phone is (616) 678-2070.

Dr. Oberlin's primary practice is Forefront Dermatology, S.C. in Grand Rapids, Michigan. Dr. Oberlin is also affiliated with Corewell Health Pennock Hospital. The medical group on file is Forefront Dermatology. Dmand AI also links Dr. Oberlin to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Oberlin practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Oberlin's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Oberlin is licensed in Michigan.

CMS data shows 3,704 Medicare services from Dr. Oberlin across 16 procedure codes in 2024, for 612 Medicare patients. Medicare paid $152,426 for them. Every service was in an office.

CMS counts 612 Medicare patients who saw Dr. Oberlin in 2024. The largest group is 65 to 74, with 305 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.07, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Oberlin's median patient age at 68, with 52% women.

In 2024, Dr. Oberlin wrote 1,957 Medicare Part D claims for 818 patients. 92% of them were for generic drugs. CMS names the drug for 1,836 of them, across 24 drugs with 11 or more claims each, at $740,155 in total drug cost. In 2023, CMS named 1,447 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Oberlin for performance year 2024, reported as part of a group. Dr. Oberlin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,041 procedures of removal of skin lesions by Dr. Oberlin, more than 93% of the clinicians it reports for that procedure.

Dmand AI links 6 papers to Dr. Oberlin, published from 2018 to 2020. Dr. Oberlin has published most often in Cutis. Dr. Oberlin's most frequent co-authors are Taylor Lee Braunberger, MD, Laurie Linden Kohen, MD and Matteo C. Lopiccolo, MD.

CMS Open Payments shows 623 general payments to Dr. Oberlin from 30 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 67% of the total. Amgen Inc. paid the most, $43,234.

Dr. Oberlin graduated from Wayne State University School of Medicine in 2015.